BIO-key International, Inc. BKYI
$2.65
-$0.10-3.60%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.92M | 2.15M | 1.08M | 1.55M | 1.70M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.92M | 2.15M | 1.08M | 1.55M | 1.70M |
| Cost of Revenue | 246.00K | 376.30K | 271.40K | 358.00K | 464.20K |
| Gross Profit | 1.67M | 1.77M | 812.40K | 1.19M | 1.23M |
| SG&A Expenses | 1.56M | 1.31M | 1.83M | 1.40M | 1.68M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.45M | 2.30M | 2.79M | 2.44M | 2.78M |
| Operating Income | -529.40K | -157.70K | -1.71M | -892.20K | -1.08M |
| Income Before Tax | -576.90K | -205.00K | -4.27M | -964.80K | -1.17M |
| Income Tax Expenses | -- | -- | 16.50K | -- | -- |
| Earnings from Continuing Operations | -576.90K | -205.00K | -4.29M | -964.80K | -1.17M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -576.90K | -205.00K | -4.29M | -964.80K | -1.17M |
| EBIT | -529.40K | -157.70K | -1.71M | -892.20K | -1.08M |
| EBITDA | -455.30K | -87.00K | -1.64M | -814.60K | -983.40K |
| EPS Basic | -0.56 | -0.20 | -4.62 | -1.46 | -2.01 |
| Normalized Basic EPS | -0.35 | -0.12 | -1.19 | -0.92 | -1.25 |
| EPS Diluted | -0.56 | -0.20 | -4.62 | -1.46 | -2.01 |
| Normalized Diluted EPS | -0.35 | -0.12 | -1.19 | -0.92 | -1.25 |
| Average Basic Shares Outstanding | 1.04M | 1.04M | 929.40K | 658.80K | 582.10K |
| Average Diluted Shares Outstanding | 1.04M | 1.04M | 929.40K | 658.80K | 582.10K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |